BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12623109)

  • 1. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
    Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
    Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
    Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
    Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma.
    Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH
    Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2004 May; 10(9):1281-5. PubMed ID: 15112342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
    Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
    Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
    Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
    Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
    Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
    Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
    Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
    Duan XY; Wang JS; Liu M; Guo YM
    Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
    J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
    Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.
    Kao CH; Tsai SC; Liu TJ; Ho YJ; Wang JJ; Ho ST; ChangLai SP
    Cancer Res; 2001 Feb; 61(4):1412-4. PubMed ID: 11245443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression in pituitary adenoma.
    Kunishio K; Okada M; Matsumoto Y; Nagao S; Nishiyama Y
    J Med Invest; 2006 Aug; 53(3-4):285-91. PubMed ID: 16953066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
    Tatsumi M; Tsuruo T; Nishimura T
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Cancer Lett; 2000 May; 153(1-2):95-100. PubMed ID: 10779636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.